Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib

od Schoenfeld, A.J., Arbour, K.C., Rizvi, H., Iqbal, A.N., Gadgeel, S.M., Girshman, J., Kris, M.G., Riely, G.J., Yu, H.A., Hellmann, M.D.
izdano v Ann Oncol (2019)

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

od Osorio, J. C., Ni, A., Chaft, J. E., Pollina, R., Kasler, M. K., Stephens, D., Rodriguez, C., Cambridge, L., Rizvi, H., Wolchok, J. D., Merghoub, T., Rudin, C. M., Fish, S., Hellmann, M. D.
izdano v Ann Oncol (2017)

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

od Derosa, L, Hellmann, M D, Spaziano, M, Halpenny, D, Fidelle, M, Rizvi, H, Long, N, Plodkowski, A J, Arbour, K C, Chaft, J E, Rouche, J A, Zitvogel, L, Zalcman, G, Albiges, L, Escudier, B, Routy, B
izdano v Ann Oncol (2018)

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure

od Rivellese, F., Humby, F., Bugatti, S., Fossati‐Jimack, L., Rizvi, H., Lucchesi, D., Lliso‐Ribera, G., Nerviani, A., Hands, R. E., Giorli, G., Frias, B., Thorborn, G., Jaworska, E., John, C., Goldmann, K., Lewis, M. J., Manzo, A., Bombardieri, M., Pitzalis, C.
izdano v Arthritis Rheumatol (2020)

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

od Gainor, J. F., Rizvi, H., Aguilar, E. Jimenez, Skoulidis, F., Yeap, B. Y., Naidoo, J., Khosrowjerdi, S., Mooradian, M., Lydon, C., Illei, P., Zhang, J., Peterson, R., Ricciuti, B., Nishino, M., Zhang, J., Roth, J. A., Grishman, J., Anderson, D., Little, B. P., Carter, B. W., Arbour, K., Sauter, J. L., Mino-Kenudson, M., Heymach, J. V., Digumarthy, S., Shaw, A. T., Awad, M. M., Hellmann, M. D.
izdano v Ann Oncol (2019)

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

od Hastings, K, Yu, H A, Wei, W, Sanchez-Vega, F, DeVeaux, M, Choi, J, Rizvi, H, Lisberg, A, Truini, A, Lydon, C A, Liu, Z, Henick, B S, Wurtz, A, Cai, G, Plodkowski, A J, Long, N M, Halpenny, D F, Killam, J, Oliva, I, Schultz, N, Riely, G J, Arcila, M E, Ladanyi, M, Zelterman, D, Herbst, R S, Goldberg, S B, Awad, M M, Garon, E B, Gettinger, S, Hellmann, M D, Politi, K
izdano v Ann Oncol (2019)

COVID-19 in patients with lung cancer

od Luo, J., Rizvi, H., Preeshagul, I.R., Egger, J.V., Hoyos, D., Bandlamudi, C., McCarthy, C.G., Falcon, C.J., Schoenfeld, A.J., Arbour, K.C., Chaft, J.E., Daly, R.M., Drilon, A., Eng, J., Iqbal, A., Lai, W.V., Li, B.T., Lito, P., Namakydoust, A., Ng, K., Offin, M., Paik, P.K., Riely, G.J., Rudin, C.M., Yu, H.A., Zauderer, M.G., Donoghue, M.T.A., Łuksza, M., Greenbaum, B.D., Kris, M.G., Hellmann, M.D.
izdano v Ann Oncol (2020)